Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23402625 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effects of Antiviral Therapy on HBV Reactivation
Condition: Liver Cancer
Intervention: Drug: Entecavir therapy
2 Unknown  Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
Condition: Hepatocellular Carcinoma
Intervention: Drug: Lamivudine 100mg once daily; or Entecavir 0.5mg once daily.

Indicates status has not been verified in more than two years